Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |||
Bronchospasm | x | x | ||||||
Diarrhoea | x | x | x | x | ||||
Eczema | x | x | ||||||
Rash | x | x | x | x | x | |||
Hypersensitivity | x | x | x | |||||
Nausea | x | x | x | x | ||||
Pain | x | x | ||||||
Pruritus | x | x | x | |||||
Stevens-Johnson syndrome | x | x | ||||||
Tachycardia | x | x | ||||||
Urticaria | x | x | ||||||
Vomiting | x | x | x | x | ||||
Diarrhoea haemorrhagic | x | x | ||||||
Swelling face | x | x | ||||||
Myalgia | x | x | ||||||
Mouth irritation | x | x | ||||||
Anaphylactoid reaction | x | |||||||
Gastrointestinal symptom NOS | x | |||||||
Distress gastrointestinal | x | x | ||||||
Sensitisation | x | x | ||||||
Gastrointestinal tract irritation | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |